Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia (Q43913079)

28 November 2017

Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia (English)

1 reference

28 November 2017

0 references

Pouzet B

1

1 reference

28 November 2017

Didriksen M

series ordinal

2

1 reference

28 November 2017

Arnt J

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Pharmacology, Biochemistry and Behavior

28 November 2017

1 reference

28 November 2017

71

1 reference

28 November 2017

4

1 reference

28 November 2017

635-643

1 reference

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Involvement of 5-HT6 receptors in nigro-striatal function in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

5-ht6 receptors as emerging targets for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Central distribution and function of 5-HT6 receptor subtype in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

Clozapine downregulates 5-hydroxytryptamine6 (5-HT6) and upregulates 5-HT7 receptors in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900743-2

7 January 2021

10.1016/S0091-3057(01)00743-2

Identifiers

DOI

1 reference

28 November 2017

1 reference